Search market news

Boule Diagnostics Q3 Sales Fall on Weak Instrument Demand

Quest Diagnostics Reports Quarterly Results for Period Ended Sept. 30

Quest Diagnostics Reports Q3 Results and Raises 2026 Guidance

Quest Diagnostics reported adjusted EPS of $3.00 and revenue of $3.10 billion, above FactSet estimates of $2.87 and $3.05 billion, respectively. It raised its 2026 revenue guidance to $12.07 billion-$12.11 billion and adjusted EPS guidance to $11.25-$11.35.

Quest Diagnostics Expected to Post $2.86 per Share in Earnings

An earnings preview cites expected earnings of $2.86 per share for Quest Diagnostics.

DIARY — U.S. earnings week ahead

Oct 16 (Reuters) — Diary of U.S. (.SPX) corporate earnings for the week ahead. U.s. Earnings Start Date Start Time RIC Company Name Event Name 19-Oct-2026 BMO FITB Fifth Third Bancorp Q3 2026 Fifth Third Bancorp Earnings Release 19-Oct-2026 AMC STLD.O Steel Dynamics Inc Q3 2026 Steel Dynamics Inc Earnings Release 19-Oc

GTH signs term sheet for an investment in Zirnostics GmbH and secures comprehensive investor rights

German Tech Holding GmbH & Co. KGaA by Investor Relations Business news for the stock market German Tech Holding GmbH & Co. KGaA: GTH signs term sheet for an investment in Zirnostics GmbH and secures comprehensive investor rights Frankfurt am Main (pta000/13.10.2026/17:05 UTC+2) German Tech Holding signs term sheet for

AcuityMD Launches Research Agent in AcuityAI to Take MedTech Market Analysis from Weeks to Minutes

For best results when printing this announcement, please click on link below: AcuityMD Launches Research Agent in AcuityAI to Take MedTech Market Analysis from Weeks to Minutes AcuityMD ( ), the AI platform for MedTech, today introduced advanced market analysis in AcuityAI ( ), powered by a new research agent that deli

Novacyt H1 revenue rises 18% to £11.6m after Southern Cross Diagnostics acquisition

France molecular diagnostics firm Novacyt said H1 revenue rose 18% year-on-year to £11.6m. Gross margin fell to 56% from 66%, citing dilution from Southern Cross Diagnostics and lower Primer Design sales; it expects continued organic growth in H2 and further opex reductions in H2 with full annualised benefit in 2027.

France's Novacyt H1 revenue rises on Southern Cross Diagnostics acquisition

OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automati…

Kimball Electronics Reports Q4 2026 Results: Full Earnings Call Transcript

Kimball Electronics (NASDAQ: KE ) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Kimball Electronics reported Q4 sales of $372 mil

Transcript: Henry Schein Q2 2026 Earnings Conference Call

Henry Schein (NASDAQ: HSIC ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Henry Schein Inc reported strong financial performance in the se

UK's EKF Diagnostics H1 revenue flat, gross margin rises

OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

Quest Diagnostics Incorporated (NYSE: DGX ) stock surged Thursday after the diagnostic testing company reported second-quarter results that topped Wall Street expectations and raised its full-year 2026 guidance. Earnings And Revenue Top Estimates Adjusted earnings rose to $3.12 per share, beating the analyst consensus

Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday

U.S. stocks were lower, with the Dow Jones index dipping around 450 points on Thursday. Shares of Lockheed Martin Corp (NYSE: LMT ) rose sharply after the company reported better-than-expected second-quarter financial results and raised its FY26 guidance above estimates. Lockheed Martin reported quarterly earnings of $

Abbott Laboratories Reports Q2 2026 Results: Full Earnings Call Transcript

Abbott Laboratories (NYSE: ABT ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Abbott Laboratories reported a 4.8%

Quest Diagnostics Estimates

Analysts update Quest Diagnostics stock estimates and ratings. No change to outlook.